carbapenems has been researched along with Agammaglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imafuku, K; Itamoto, S; Kawamura, T; Kimura, A; Kosumi, H; Mai, Y; Muramatsu, K; Nakakubo, S; Shiiya, C; Ujiie, H; Yamada, M; Yanagi, T; Youh, J | 1 |
| Akeda, Y; Hagiya, H; Kimura, K; Nishi, I; Tomono, K; Yamamoto, N; Yoshida, H | 1 |
2 other study(ies) available for carbapenems and Agammaglobulinemia
| Article | Year |
|---|---|
Macrolide/fluoroquinolone-resistant Campylobacter jejuni-induced cellulitis in a patient with X-linked agammaglobulinaemia successfully treated with carbapenem.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Campylobacter jejuni; Carbapenems; Cellulitis; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Diseases, X-Linked; Humans; Macrolides | 2021 |
Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia.
Topics: Adult; Agammaglobulinemia; Anti-Bacterial Agents; Bacteremia; Campylobacter coli; Campylobacter Infections; Carbapenems; Drug Resistance, Bacterial; Genetic Diseases, X-Linked; Humans; Infusions, Intravenous; Long-Term Care; Male | 2018 |